EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 1 filers reported holding EPIZYME INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,035,000 | +27.8% | 3,425,202 | 0.0% | 1.40% | +32.4% |
| Q1 2022 | $3,939,000 | -54.0% | 3,425,202 | 0.0% | 1.06% | -32.3% |
| Q4 2021 | $8,563,000 | -57.9% | 3,425,202 | -13.8% | 1.56% | -50.5% |
| Q3 2021 | $20,341,000 | +5.0% | 3,972,830 | +70.4% | 3.16% | -0.9% |
| Q2 2021 | $19,375,000 | -4.6% | 2,331,534 | 0.0% | 3.18% | +24.7% |
| Q1 2021 | $20,308,000 | -63.9% | 2,331,534 | -55.0% | 2.55% | -47.5% |
| Q4 2020 | $56,322,000 | +65.4% | 5,186,271 | +81.7% | 4.86% | -40.7% |
| Q3 2020 | $34,057,000 | -9.0% | 2,854,737 | +22.4% | 8.20% | -17.6% |
| Q2 2020 | $37,444,000 | +3.5% | 2,331,534 | 0.0% | 9.96% | -54.9% |
| Q1 2020 | $36,162,000 | -37.0% | 2,331,534 | 0.0% | 22.09% | +8.7% |
| Q4 2019 | $57,356,000 | – | 2,331,534 | – | 20.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |